PMVP
USDPMV Pharmaceuticals Inc. Common Stock
$1.340-0.040 (-2.899%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.380
High
$1.430
Low
$1.320
Volume
0.37M
Company Fundamentals
Market Cap
71.0M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.26M
Exchange
NMS
Currency
USD
52-Week Range
Low $0.81Current $1.340High $1.84
Related News
GlobeNewswire
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Confirmed responses observed in eight tumor types spanning ovarian, lung, breast,
View more
GlobeNewswire
PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Oral presentation to highlight initial data from ongoing pivotal Phase 2 study of rezatapopt, a first-in-class precision oncology investigational therapy, in patients with advanced solid tumors harboring a TP53 Y220C
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.